More from Pfizer Oncology...

Discussion in 'Pfizer' started by anonymous, Jun 28, 2019 at 10:16 AM.

Tags: Add Tags
  1. anonymous

    anonymous Guest

    Today Pfizer’s oncology expansion got a boost with the FDA approval of biosimilar Zirabev. Good for Pfizer that the approval came shortly after its buyout of Array Pharma and good for people looking for an alternative treatment option that is reliable. There should be more of this kind coming from Pfizer considering its aggressive generic push….
     

  2. anonymous

    anonymous Guest

    There are already more of this kind with more on the way.

    The concern is who will be left with the relationships and experience to get access needed to promote these products? With just a few years of oncology experience, recruiters are more relentless than ever. Is it true that we can make $30k-$50k more at a biotech?
     
  3. anonymous

    anonymous Guest

    Not a clinical sell - all about pricing. And, hate to break it to you, but small startups and biotechs are not inclined to hire Pfizerbots.
     
  4. anonymous

    anonymous Guest

    Recruiters are the scum of the earth.
    No.
     
  5. anonymous

    anonymous Guest

    Oncology is the best division in Pfizer.
     
  6. anonymous

    anonymous Guest

    Yes. The smaller companies pay much better
     
  7. anonymous

    anonymous Guest

    If they will hire you....
     
  8. anonymous

    anonymous Guest

    Get real,,,,, biotech is not calling our reps.
     
  9. anonymous

    anonymous Guest

    Harsh